Академический Документы
Профессиональный Документы
Культура Документы
3. 4.
3. B.
g-hemolysis
C.
Growth char:
3.
4.
5.
Lipoteichoic acid
6.
Streptokinase (fibrinolysin)
7.
8. Hyaluronidase (spreading factor) 9. Diphosphopyridine Nucleotidase10. Pyrogenic exotoxins (erythrogenic toxins) Types: a. Exotoxin A b. c. Exotoxin B Exotoxin C
ii.
Streptolysin S
Pathogenesis & Clinical Findings 1. Streptococcal pharyngitis/ sore throat 2. Skin infections
3.
Scarlet fever
4.
Strep. TSS
5.
b.
Rheumatic fever
F.
Treatment:
Streptococcus agalactiae
Diagnostic test: Sample: HVS- women, blood and CSF- new born Culture= B-hemolysis, may show double zone of hemolysis- anaerobically 1. CAMP test (Christie, Atkins, Munch, Petterson)
2.
Hippurate test
Non-Enterococci
2.
LAP test
3.
PYR test
4.
5.
Streptococcus pneumonia
Cultural char:
Antigenic structure:
Clinical features:
PREDISPOSING FACTORS 1. Viral & other respiratory tract infections 2. Alcohol or drug intoxication
3.
4.
Other mechanisms- malnutrition, general debility, sickle cell anemia, hyposplenism, nephrosis, or complement deficiency.
Pneumococci Bile solubility Inulin fermentation Capsular swelling Quinidine Optochin Mouse virulence test 4. Bile solubility test
Streptococci
5.
Optochin test
6.
Quellung Reaction
Treatment: Penicillin G is the drug of choice cephalosporin or erythromycin (pneumonia),chloramphenicol (meningitis), quinolones Vaccines - Capsular antigen vaccine- for older adults and other high risk individuals, effective 5 years - Conjugate vaccine- for children 2-23 months
Peptostreptococcus